Skip to main content

Medications for Pancreatic Cancer

The medications listed below are related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
Abraxane 1.0 1 review for Abraxane to treat Pancreatic Cancer
Rx D N
Generic name:
paclitaxel protein-bound systemic
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
Afinitor 9.0 1 review for Afinitor to treat Pancreatic Cancer
Rx D N
Generic name:
everolimus systemic
Drug class:
mTOR inhibitors, selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
bevacizumab Off-label 9.0 1 review for bevacizumab to treat Pancreatic Cancer
Rx C N
Generic name:
bevacizumab systemic
Drug class:
VEGF/VEGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Off-label:
Yes
capecitabine 1.0 2 reviews for capecitabine to treat Pancreatic Cancer
Rx D N
Generic name:
capecitabine systemic
Brand name:
Xeloda
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
cetuximab Off-label Rate Add review
Rx C N
Generic name:
cetuximab systemic
Drug class:
EGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Off-label:
Yes
erlotinib 5.7 3 reviews for erlotinib to treat Pancreatic Cancer
Rx D N
Generic name:
erlotinib systemic
Drug class:
EGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
everolimus 9.0 1 review for everolimus to treat Pancreatic Cancer
Rx D N
Generic name:
everolimus systemic
Brand name:
Afinitor
Drug class:
mTOR inhibitors, selective immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
fluorouracil Rate Add review
Rx D N
Generic name:
fluorouracil systemic
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
gemcitabine 8.0 4 reviews for gemcitabine to treat Pancreatic Cancer
Rx D N
Generic name:
gemcitabine systemic
Brand names:
Gemzar, Infugem
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Gemzar 8.0 4 reviews for Gemzar to treat Pancreatic Cancer
Rx D N
Generic name:
gemcitabine systemic
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Infugem Rate Add review
Rx D N
Generic name:
gemcitabine systemic
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
irinotecan liposomal Rate Add review
Rx N
Generic name:
irinotecan liposomal systemic
Brand name:
Onivyde
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
Lynparza 1.0 1 review for Lynparza to treat Pancreatic Cancer
Rx D N
Generic name:
olaparib systemic
Drug class:
PARP inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
methotrexate Off-label Rate Add review
Rx X N X
Generic name:
methotrexate systemic
Drug class:
antimetabolites, antirheumatics, antipsoriatics, other immunosuppressants
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Off-label:
Yes
mitomycin Rate Add review
Rx N N
Generic name:
mitomycin systemic
Brand name:
Mutamycin
Drug class:
antibiotics/antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Mutamycin Rate Add review
Rx N N
Generic name:
mitomycin systemic
Drug class:
antibiotics/antineoplastics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
olaparib 1.0 1 review for olaparib to treat Pancreatic Cancer
Rx D N
Generic name:
olaparib systemic
Brand name:
Lynparza
Drug class:
PARP inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Onivyde Rate Add review
Rx N
Generic name:
irinotecan liposomal systemic
Drug class:
miscellaneous antineoplastics
For consumers:
dosage, interactions, side effects
paclitaxel protein-bound 5.0 2 reviews for paclitaxel protein-bound to treat Pancreatic Cancer
Rx D N
Generic name:
paclitaxel protein-bound systemic
Brand name:
Abraxane
Drug class:
mitotic inhibitors
For consumers:
dosage, interactions, side effects
pancreatin Off-label Rate Add review
Rx/OTC C N
Generic name:
pancreatin systemic
Drug class:
digestive enzymes
For consumers:
interactions, side effects
Off-label:
Yes
streptozocin Rate Add review
Rx D N
Generic name:
streptozocin systemic
Brand name:
Zanosar
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
sunitinib 5.0 2 reviews for sunitinib to treat Pancreatic Cancer
Rx D N
Generic name:
sunitinib systemic
Brand name:
Sutent
Drug class:
multikinase inhibitors, VEGF/VEGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Sutent 5.0 2 reviews for Sutent to treat Pancreatic Cancer
Rx D N
Generic name:
sunitinib systemic
Drug class:
multikinase inhibitors, VEGF/VEGFR inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Xeloda Rate Add review
Rx D N
Generic name:
capecitabine systemic
Drug class:
antimetabolites
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Zanosar Rate Add review
Rx D N
Generic name:
streptozocin systemic
Drug class:
alkylating agents
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information

Frequently asked questions

View more FAQ

Learn more about Pancreatic Cancer

Care guides

Symptoms and treatments

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.